IL-5 receptor alpha subunit antagonist

This page covers all IL-5 receptor alpha subunit antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting IL-5Rα.

Targets

IL-5Rα

Phase 3 pipeline (1)

• Placebo to Benralizumab · AstraZeneca · Respiratory
  Benralizumab is a monoclonal antibody that targets the interleukin-5 receptor alpha subunit, leading to the depletion of eosinophils.

Patent intelligence

• il 5 receptor alpha subunit antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates